In vitro and in vivo activities of LB10522, a new catecholic cephalosporin

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 8, 1996, Pages 1825-1831

  Kim, Mu Yong ^a   Oh, Jeong In ^a   Paek, Kyoung Sook ^a   Kim, Yong Zu ^a   Kim, In Chull ^a   Kwak, Jin Hwan ^a  

^a LG Chemical Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOPERAZONE; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; LB 10522; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG HYDROLYSIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; SALMONELLA; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029800025     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1825     Document Type: Article

References (23)

1. Arisawa, M., Y. Sekine, S. Shimizu, H. Takano, P. Angehrn, and R. L. Then. 1991. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity. Antimicrob. Agents Chemother. 35:653-659.
2. Arnould, J. C., A. Bertrandie, T. G. C. Bird, D. Boucherot, F. Jung, J. J. Lohmann, and A. Olivier. 1992. Synthesis and structure-activity relationship of cephalosporins with C-3′ catechol-containing residues. J. Med. Chem. 35:2631-2642.
3. Aszodi, J., D. Humbert, A. Bonnefoy, P. Collette, P. Mauvais, and J. F. Chantot. 1994. RU 59863, a novel catechol-substituted vinylogous cephalosporin: in-vitro antibacterial activity, abstr. F99, p. 161. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Bliss, C. I. 1985. The statistics in bioassay. Academic Press, Inc., New York.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. Curtis, N. A. C., R. L. Eisenstadt, S. J. East, R. J. Comford, L. A. Walker, and A. J. White. 1988. Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins. Antimicrob. Agents Chemother. 32:1879-1886.
8. Erwin, M. E., R. N. Jones, M. S. Barrett, B. M. Briggs, and D. M. Johnson. 1991. In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin. Antimicrob. Agents Chemother. 35:929-937.
9. Jones, R. N., and M. E. Erwin. 1992. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin. Antimicrob. Agents Chemother. 36:233-238.
10. Hartmann, A., and V. Braun. 1980. Iron transport in Escherichia coli: uptake and modification of ferrichrome. J. Bacteriol. 143:246-255.
11. Kim, M.-Y., H.-K. Song, J.-I. Oh, M.-K. Seo, Y.-H. Lee, I.-C. Kim, and J.-H. Kwak. 1995. LB10522, a new catechol-substituted cephalosporin. II. β-Lactamase stabilities and biological activities, abstr. F42, p. 120. In Abstracts of the 35th Interscicnce Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
12. Maejima, T., M. Inoue, and S. Mitsuhashi. 1991. In vitro antibacterial activity of KP-736, a new cephem antibiotic. Antimicrob. Agents Chemother. 35:104-110.
13. Mochizuki, H., H. Yamada, Y. Oikawa, K. Murakami, J. Ishiguro, H. Kosuzume, N. Arizawa, and E. Mochida. 1988. Bactericidal activity of M14659 enhanced in low-iron environments. Antimicrob, Agents Chemother. 32: 1648-1654.
14. Nakagawa, S., M. Sanada, K. Matsuda, T. Hashizume, Y. Asahi, R. Ushijima, N. Ohtake, and N. Tanaka. 1989. In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin. Antimicrob. Agents Chemother. 33:1423-1427.
15. Nakagawa, S., M. Sanada, K. Matsuda, N. Hazumi, and N. Tanaka. 1987. Biological activity of BO-1236, a new antipseudomonal cephalosporin. Antimicrob. Agents Chemother. 31:1100-1105.
16. National Committee for Clinical Laboratory Standards. 1992. Methods for determining bactericidal activity of antimicrobial agents. M26-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd edition. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Ogino, H., K. Iwamatsu, K. Katano, S. Nakabayashi, T. Yoshida, T. Tsuruoka, S. Inouye, and S. Kondo. 1990. New aminothiazolyglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. I. Synthesis and biological activity of cephalosporin derivatives leading to M0703. J. Antibiotics 43:174-188.
19. Oh, J.-I., K.-S. Baek, H.-K. Song, M.-Y. Kim, Y.-Z. Kim, I.-C. Kim, and J.-H. Kwak. 1995. LB10522, a new catechol-substituted cephalosporin. I. In vitro and in vivo antibacterial activities, abstr. F41, p. 120. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Pollock, M. R. 1986. Purification and properties of penicillinase from two strains of Bacillus licheniformis: a chemical, physicochemical and physiological comparison. Biochem. J. 94:666-675.
21. Shinzo, K., S, Arai, S. Hayashi, and K. Fujimoto. 1986. β-Lactamase stability of cefpirome (HR810), a new cephalosporin with a broad antimicrobial spectrum. Antimicrob. Agents Chemother. 30:713-718.
22. Silley, P., J. W. Griffiths, D. Monsey, and A. M. Harris. 1990. Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system. Antimicrob. Agents Chemother. 34:1806-1808.
23. Watanabe, N.-A., T. Nagasu, K. Katsu, and K. Kitoh. 1987. E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system. Antimicrob. Agents Chemother. 31:497-504.